Tetracaine

Generic Name
Tetracaine
Brand Names
Ametop, Cetacaine, Kovanaze, One Touch Reformulated Apr 2009, Pliaglis, Synera, Zap
Drug Type
Small Molecule
Chemical Formula
C15H24N2O2
CAS Number
94-24-6
Unique Ingredient Identifier
0619F35CGV
Background

Tetracaine is an ester local anaesthetic currently available in combination with lidocaine as a cream and patch.

Indication

Ophthalmic tetracaine is indicated for the for procedures requiring a rapid and short- acting topical ophthalmic anesthetic.
...

Associated Conditions
Dermabrasion, Haemorrhoids, Insect Bites, Rash caused by poison ivy, Sunburn, Minor burns
Associated Therapies
Local Anaesthesia therapy, Local Anesthesia of the Skin

Pharmacokinetic Study of Synera in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-05-21
Last Posted Date
2012-10-17
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
12
Registration Number
NCT01602757
Locations
🇺🇸

Cetero Research, Fargo, North Dakota, United States

Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow

First Posted Date
2012-02-02
Last Posted Date
2014-03-05
Lead Sponsor
International Clinical Research Institute
Target Recruit Count
78
Registration Number
NCT01525043
Locations
🇺🇸

International Clinical Research Institute, Overland Park, Kansas, United States

Intravitreal Injection Anesthesia - Comparison of Different Topical Agents

First Posted Date
2010-10-20
Last Posted Date
2012-04-19
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
92
Registration Number
NCT01224847
Locations
🇨🇦

Ivey Eye Institute, London, Ontario, Canada

Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2009-11-01
Last Posted Date
2017-11-08
Lead Sponsor
Wake Forest University
Target Recruit Count
46
Registration Number
NCT01005459
Locations
🇺🇸

Forsyth Medical Center- OB Anesthesia dept, Winston-Salem, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath